A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative (original ) (raw )A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization
John Harlock
Canadian Journal of Cardiology, 2021
View PDFchevron_right
Antithrombotic Therapy in Peripheral Artery Disease
Graham McClure
Chest, 2012
View PDFchevron_right
Effectiveness and safety of anticoagulant versus antiplatelet therapy in patients after endovascular revascularisation of the lower limb
Natasa Kejzar
Slovenian Medical Journal
View PDFchevron_right
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial
Xavier García-moll
Drugs in Context
View PDFchevron_right
Antiplatelet Therapy and Other Interventions after Revascularisation Procedures in Patients with Peripheral Arterial Disease: a Meta-analysis
Martin Prins
European Journal of Vascular and Endovascular Surgery, 2000
View PDFchevron_right
A Review of Antithrombotic Treatment in Critical Limb Ischemia After Endovascular Intervention
Amol Gupta
Cardiology and Therapy, 2019
View PDFchevron_right
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions
Giuseppe Giugliano
Journal of Cardiovascular Development and Disease, 2023
View PDFchevron_right
Anti-platelet and anti-coagulant therapy in peripheral arterial disease prior to surgical intervention
Mika Burgess
Vascular, 2018
View PDFchevron_right
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Work...
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy, 2019
View PDFchevron_right
Thrombotic Risk Factors and Cardiovascular Events after Endovascular Intervention for Peripheral Arterial Disease
Gualtiero Palareti
European Journal of Vascular and Endovascular Surgery, 2011
View PDFchevron_right
The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention
Pierfrancesco Lapolla
CVIR Endovascular
View PDFchevron_right
Comparative effectiveness review of antiplatelet agents in peripheral artery disease
manesh patel
Journal of the American Heart Association, 2014
View PDFchevron_right
Update on the Management of Peripheral Arterial Disease (PAD)
Gee Putera
Med J Malaysia, 2011
View PDFchevron_right
A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia
Christopher Cox
Journal of Vascular Surgery, 1994
View PDFchevron_right
Comparison of Antiplatelet and Antithrombotic Therapy for Secondary Prevention of Ischemic Stroke in Patients With Peripheral Artery Disease
Po-chao Hsu
Circulation Journal, 2013
View PDFchevron_right
Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia
Tomasz Nowakowski
Journal of Thrombosis and Thrombolysis
View PDFchevron_right
High plateletcrit is associated with early loss of patency after open and endovascular interventions for chronic limb ischemia
Nader D. Nader
Journal of Vascular Surgery, 2019
View PDFchevron_right
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease
Giovanni Cafaro
Annals of Medicine, 2014
View PDFchevron_right
European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases
Miltiadis Matsagkas
Journal of Vascular Surgery, 2023
View PDFchevron_right
Peripheral Arterial Disease - antiplatelet therapy
Debora Karetová
2010
View PDFchevron_right
Management of chronic peripheral artery disease patients with indication for endovascular revascularization
Juraj Madaric
Vasa
View PDFchevron_right
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease
Alberico Catapano
Atherosclerosis, 2021
View PDFchevron_right
Guided Antithrombotic Therapy: Current Status and Future Research Direction
Jeffrey Weitz
Circulation, 2012
View PDFchevron_right
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery
Martin Prins
Protocols, 1996
View PDFchevron_right
Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia
Sreekanth Vemulapalli
American Heart Journal, 2014
View PDFchevron_right
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy
Christine Espinola-klein
European Heart Journal, 2021
View PDFchevron_right
Peripheral thrombolysis: state of the art
Jonothan Earnshaw
Cardiovascular Surgery, 1995
View PDFchevron_right
Supplemental material for Anti-platelet and anti-coagulant therapy in peripheral arterial disease prior to surgical intervention
Mika Burgess
2018
View PDFchevron_right